AKT1 and Kaposi's sarcoma: In contrast, Khakoo et al. indicated that human bone marrow-derived MSCs homed to Kaposi’s sarcoma after intravenous injection, dose-dependently inhibiting KS tumor growth by inhibiting Akt activation [124].